John Overdeck’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

John Overdeck’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,191	Closed	-$8.13K	–	3287
2022 Q4	$8.13K	Sell	2,191 -1,468	-40%	-$6.49K	﹤0.01%	2739
2022 Q3	$18K	Buy	3,659 +1,655	+83%	+$9.21K	﹤0.01%	2387
2022 Q2	$12K	Buy	+2,004	New	+$11.3K	﹤0.01%	2429
2022 Q1	–	Sell	-54,221	Closed	-$716K	–	4656
2021 Q4	$716K	Buy	+54,221	New	+$897K	﹤0.01%	2880
2021 Q2	–	Sell	-1,968	Closed	-$143K	–	4700
2021 Q1	$143K	Sell	1,968 -7,425	-79%	-$527K	﹤0.01%	3678
2020 Q4	$406K	Buy	+9,393	New	+$421K	﹤0.01%	2646
2020 Q3	–	Sell	-7,275	Closed	-$437K	–	3677
2020 Q2	$437K	Buy	7,275 +1,973	+37%	+$181K	﹤0.01%	2091
2020 Q1	$399K	Buy	5,302 +3,133	+144%	+$361K	﹤0.01%	2098
2019 Q4	$298K	Buy	+2,169	New	+$264K	﹤0.01%	3193

Other funds holding ORTX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $1.58B AUM 19.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

John Overdeck's ORTX Position: Q1 2023 in Review

John Overdeck sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 2,191 shares — an estimated $8.13K sold.

John Overdeck first reported a position in ORTX in Q4 2019 and held it in 9 quarters. The position peaked at $716K in Q4 2021. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

John Overdeck reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
John Overdeck sold 2,191 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $8.13K.
John Overdeck first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 9 quarters.
John Overdeck's Orchard Therapeutics plc American Depositary Shares position peaked at $716K in Q4 2021.
35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.